Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05550571 · ClinicalTrials.gov registry record · NA
A Medical Device to Treat Wide-Neck Brain Aneurysms
A NA study of Ruptured Cerebral Aneurysm, sponsored by EndoStream Medical.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 5
- Study locations
NCT05550571: Active NA study of Ruptured Cerebral Aneurysm, sponsored by EndoStream Medical.
NCT05550571 is a NA study of Ruptured Cerebral Aneurysm that is active but no longer recruiting, run by EndoStream Medical. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05550571, a NA study of Ruptured Cerebral Aneurysm, is active but no longer recruiting, sponsored by EndoStream Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 5
- Study locations
Study Summary
The study aims to evaluate the safety and probable benefit of a medical device to treat wide-neck ruptured brain aneurysms.
Primary Outcome
The proportion of subjects experiencing death or stroke in treated vascular territory measured using the NIH stroke scale
Conditions Studied
Interventions
- DEVICE Nautilus Intrasaccular Bridging System
Study Locations (5)
Florida
- Baptist Health Ambulatory Services, Inc. d/b/a/ Baptist Health Research Institute - Jacksonville
- University of South Florida - Tampa
New York
- The research Foundation For The State Of New York On Behalf Of The University At Buffalo - Buffalo
- Mount Sinai - New York
Sofia
- UMHAT "Sv. Ivan Rilski" EAD - Sofia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-12-17 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What the registry record for NCT05550571 still lists
NCT05550571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Ruptured Cerebral Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Nautilus Intrasaccular Bridging System is the first listed.
NCT05550571 lists 5 locations in 3 states (Florida, New York, Sofia).
Frequently Asked Questions
What is clinical trial NCT05550571 about?
NCT05550571 is a clinical study titled "A Medical Device to Treat Wide-Neck Brain Aneurysms". The study aims to evaluate the safety and probable benefit of a medical device to treat wide-neck ruptured brain aneurysms.
What is the current status of trial NCT05550571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-12-17. Estimated completion is 2026-10-01.
What conditions does trial NCT05550571 study?
This clinical trial studies the following conditions: Ruptured Cerebral Aneurysm.
What interventions are being tested in trial NCT05550571?
The interventions under investigation include: Nautilus Intrasaccular Bridging System (DEVICE).
Who is sponsoring clinical trial NCT05550571?
This trial is sponsored by EndoStream Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05550571 being conducted?
This trial has 5 study locations across Florida, New York, Sofia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05550571's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI